Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In 2015, Glenmark was the first to launch the DPP4 inhibitor, Teneligliptin (Zita Plus and Ziten), followed by a FDC of Teneligliptin + Metformin (Zita-Met Plus and Ziten-M)
An integrated view of immunometabolism
Later, Wegovy, a higher-dose formulation of semaglutide, was approved specifically for obesity treatment
It also offers a broader choice of injection site, compared to the intramuscular (IM) route for instance
Related: GLP-1 Users Now Have Curated Grocery Lists as Store Offers New Trending Options Dr
It works by mimicking a hormone that helps control blood sugar levels
US$ 22.51
US$ 26.80
US$ 28.56
